Ads
related to: kaplan meier step chart
Search results
Results From The WOW.Com Content Network
The Kaplan–Meier estimator, [1] [2] also known as the product limit estimator, is a non-parametric statistic used to estimate the survival function from lifetime data. In medical research, it is often used to measure the fraction of patients living for a certain amount of time after treatment.
For each step there is a blue tick at the bottom of the graph indicating an observed failure time. The smooth red line represents the exponential curve fitted to the observed data. A graph of the cumulative probability of failures up to each time point is called the cumulative distribution function (CDF).
Kaplan–Meier graph by treatment group in aml. The null hypothesis for a log-rank test is that the groups have the same survival. The expected number of subjects surviving at each time point in each is adjusted for the number of subjects at risk in the groups at each event time.
This cumulative distribution function is a step function that jumps up by 1/n at each of the n data points. Its value at any specified value of the measured variable is the fraction of observations of the measured variable that are less than or equal to the specified value.
Kaplan–Meier estimator; Kappa coefficient; Kappa statistic; Karhunen–Loève theorem; Kendall tau distance; Kendall tau rank correlation coefficient; Kendall's notation; Kendall's W – Kendall's coefficient of concordance; Kent distribution; Kernel density estimation; Kernel Fisher discriminant analysis; Kernel methods; Kernel principal ...
Retrieved from "https://en.wikipedia.org/w/index.php?title=Kaplan-Meier_curve&oldid=301564058"
It can be thought of as the kaplan-meier survivor function for a particular year, divided by the expected survival rate in that particular year. That is typically known as the relative survival (RS). If five consecutive years are multiplied, the resulting figure would be known as cumulative relative survival (CRS). It is analogous to the five ...
Paul Meier (July 24, 1924 – August 7, 2011) [1] was a statistician who promoted the use of randomized trials in medicine. [2] [3]Meier is known for introducing, with Edward L. Kaplan, the Kaplan–Meier estimator, [4] [5] a method for measuring how many patients survive a medical treatment from one duration to another, taking into account that the sampled population changes over time.